Finance

Lists
538965:BOM
Concord Drugs Ltd
₹75.70
+1.57%
(+1.17) 1D
Oct 1, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 538965...
Open
₹73.06
High
₹76.88
Low
₹71.15
Mkt. cap
997.35M
Avg. vol.
5.51K
Volume
3.39K
P/E ratio
33.78
52-wk high
₹92.52
52-wk low
₹61.00
EPS
₹2.24
Shares outstanding
7.86M
No. of employees
250
Open
₹73.06
High
₹76.88
Low
₹71.15
Mkt. cap
997.35M
Avg. vol.
5.51K
Volume
3.39K
P/E ratio
33.78
52-wk high
₹92.52
52-wk low
₹61.00
EPS
₹2.24
Shares outstanding
7.86M
No. of employees
250
News stories
From web sources and news partners
About Concord Drugs Ltd
CEO-
Employees250
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
102.76M
169.66M
378.88M
209.39M
Cost of goods sold
77.18M
143.91M
344.01M
169.14M
Cost of revenue
77.18M
143.91M
344.01M
169.14M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.95M
12.37M
17.53M
12.56M
Operating expense
18.01M
19.60M
23.55M
20.92M
Total operating expenses
95.19M
163.52M
367.56M
190.06M
Operating income
7.57M
6.15M
11.32M
19.33M
Other non operating income
26.00K
211.00K
-1.14M
82.00K
EBT including unusual items
2.71M
2.96M
7.48M
15.45M
EBT excluding unusual items
2.71M
2.96M
7.48M
15.45M
Income tax expense
789.00K
792.00K
2.20M
4.31M
Effective tax rate
29.08%
26.75%
29.36%
27.89%
Other operating expenses
3.67M
4.16M
2.50M
4.87M
Net income
1.92M
2.17M
5.28M
11.14M
Net profit margin
1.87%
1.28%
1.39%
5.32%
Earnings per share
-
-
-
-
Interest and investment income
-
-
334.00K
-
Interest expense
-4.88M
-3.40M
-3.04M
-3.96M
Net interest expenses
-4.88M
-3.40M
-2.71M
-3.96M
Depreciation and amortization charges
3.39M
3.07M
3.53M
3.49M
EBITDA
11.10M
9.72M
14.74M
22.74M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps